Plasmacluster Sharp technology to help asthma patients breathe better | Rare Techy
New Delhi [India], November 15 (ANI/BusinessWire India): SHARP Business Systems (India) Pvt. Ltd, a wholly owned Indian subsidiary of SHARP Corporation Japan, known worldwide for its unique technological products and solutions, today announced the results of a new study that validates the technology’s anti-aging power Plasmacluster ion (PCI) is included in Sharp Air cleaning equipment for respiratory diseases. Like asthma – a leading cause of morbidity and mortality in India. The investigative study led by Dr. Munemasa Mori, an expert in respiratory medicine and stem cell research was conducted at the famous Columbia University Irving Medical Center, a famous research center in the United States. The study was designed to investigate the effects of Plasmacluster ions on the airways and airway epithelial cells that line the airway from the nose to the lungs. This epithelial epithelium plays an important role in the secretion of mucus by expelling foreign substances in the mucus secretion from the secretory cells and uniting the motile ciliated cells. As part of the study, human tissue stem cells were first induced over a period of one month. The cultured cells formed a scaffold and were then exposed to Plasmacluster ions for 24 hours. As part of a research study, researchers found a decrease in a marker associated with highly cloudy mucus associated with air pollution in the airways of asthmatics and an increase in a marker associated with it has a smooth secreted protein associated with low-viscosity mucus that helps to improve. breath These changes prevent symptoms by improving the flow of mucus in the airways, which is a major problem for people with asthma. Commenting on the development, Narita Osamu, Managing Director, SHARP Business Systems (India) Pvt. Ltd said, “Continuously rising pollution levels across India’s cities have raised new challenges, making it difficult to access clean and natural gas. Concerns such as Asthma, where the increase in pollution poses a health risk. Among the growing concerns, new research results show the positive effect of Plasmacluster ion technology in reducing the secretion of airway mucus, making asthma patients more comfortable. have proven effective in identifying and removing toxic air pollutants from indoor air, and we continue to work with experts and companies to learn and improve the effectiveness of our products to ensure a clean and safe environment for all.” Dr. Munemasa Mori, Assistant Professor, Columbia University Department of Medicine, said, “I was interested in how the Plasmacluster technology, with its great ability to reduce viruses, affects the respiratory system of Humans. Experiments showed Plasmacluster ions directly to airway epithelial cells differentiated from human tissue stem cells and observed changes in mucus markers. to investigate further evaluation the effects of Plasmacluster ions on airway epithelial cells using patient-derived cells, long-term results, exploring the possible mechanism, etc. their contribution to new medicines.” Since the introduction in 2000 of the first air purifiers equipped with Plasmacluster ion technology, Sharp’s air cleaning technology has proven effective against the new coronavirus (SARS-CoV-2), viruses, bacteria, mold and odors. Sharp has sold more than 100 million products across 23 categories, equipped with Plasmacluster ion technology, including air cleaners, air conditioners, refrigerators and other product categories. PCI technology has been tested and validated by more than 35 international scientific institutions including IIT Delhi. Using Plasmacluster technology, negative hydrogen ions and positive hydrogen ions are released simultaneously, and the positive and negative ions directly bind to airborne germs, fungi, viruses, and allergens. By chemically degrading the proteins on the surface, this air filtration method reduces bacterial activity. More than 13 test facilities outside of Japan have tested the effectiveness of Plasmacluster technology in preventing the action of harmful substances such as airborne Serratia bacteria that are a source of diseases in received at the hospital (Dr. Melvin W. First, US), avian influenza viruses. (Institute Pasteur, Vietnam), and clinical effectiveness in reducing the incidence of tuberculosis in tuberculosis hospitals (National Center of Tuberculosis and Lung Diseases, Georgia). Results of the Verification Test conducted by Columbia University, USA
During the experiment, no visible negative-morphological changes or damage of epithelial epithelial cells in human lungs were confirmed after exposure to Plasmacluster ions for 24 hours. In addition to this, – The reduction of MUC5AC, a protein marker related to respiratory failure by increasing high-viscous mucus in the respiratory tract of asthmatics was confirmed in after exposure to Plasmacluster ions.
– An increase in SCGB1A1, a protein signal linked to helping to improve breathing by increasing low-viscosity mucus was found after exposure to Plasmacluster ions This story is by BusinessWire India . ANI is not responsible for the content of this article. (ANI/BusinessWire India)
(This content has not been edited by Devdiscourse staff and is auto-generated from an aggregated feed.)